. Author manuscript; available in PMC: 2021 Jul 19.

Published in final edited form as: BJU Int. 2019 Jun 26;124(5):768–774. doi: 10.1111/bju.14835

Table 2.

Baseline clinical, imaging, and biopsy results

	AA Men (32)	Non-AA Men (258)	P-value
Age (years)	58.9 ± 8.4	63.0 ± 6.9	<0.01*
PSA (ng/ml)	6.3 ± 4.2	6.0 ± 3.8	0.30
MRI Volume (cm³)	56.6 ± 28.9	53.3 ± 24.4	0.48
Largest Lesion Size (cm.)	1.1 ± 0.5	1.2 ± 0.5	0.29
High MRI Suspicion Score, n	12 (37.5%)	90 (34.9%)	0.77
No lesions seen on MRI, n	1 (3.1%)	8 (3.1%)	0.99
Dominant Anterior Tumor on MRI, n	13 (40.6%)	95 (36.8%)	0.68
GG 2, n	7 (21.9%)	76 (29.5%)	0.17
Mean Percentage of Total Biopsy Cores Positive	11.6 ± 10.5%	13.2 ± 11.9%	0.49
Mean Maximum Percentage of Core Positive	13.5 ± 16.2%	14.9 ± 16.2	0.65

P-values < 0.05 considered statistically significant and denoted with *.

AA = African-American, GG = Gleason Grade Group